Rezolute (RZLT) Preferred Dividend Payments (2016 - 2019)
Rezolute recorded quarterly Preferred Dividend Payments of $2.2 million in Q1 2019, down 62.24% quarter-over-quarter from $5.9 million in Q2 2016.
Rezolute's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $2.2 million for Q1 2019.
- In Q1 2019, Preferred Dividend Payments changed N/A year-over-year to $2.2 million; the TTM figure through Mar 2019 stood at $8.1 million (changed N/A YoY), while the FY2016 annual figure was $6.0 million, changed N/A from the prior year.
- Preferred Dividend Payments came in at $2.2 million for Q1 2019 at Rezolute, down from $5.9 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $5.9 million in Q2 2016 to a low of $61279.0 in Q1 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 2.23 Mn |
| Jun 30, 2016 | 5.91 Mn |
| Mar 31, 2016 | 61,279.00 |